CD70 and head and neck squamous cell carcinoma: We and others have previously uncovered a subset of CD70-expressing CAFs in colorectal cancer (CRC) and head and neck squamous cell carcinoma, and identified them as an adverse prognostic factor for CRC patients [18–20].